Tango Therapeutics, Inc. · NASDAQ:TNGX

Raymond Debbane's stake in Tango Therapeutics, Inc. fell to 4.00% (Schedule 13G/A)

Event Mar 31, 2026 · Filed May 4, 2026

Raymond Debbane's stake in Tango Therapeutics, Inc. fell to 4.00%, 5,657,105 shares, as a passive investor on Mar 31, 2026. Filed May 4, 2026 (Schedule 13G/A).

Stake
4.00%
Shares
5,657,105
Intent
Passive
What changed
Fell below 5%
Filed together
8 holders

The filing in full

HolderStakeShares
Invus Public Equities, L.P.3.50%4,964,650
Invus Public Equities Advisors, LLC3.50%4,964,650
Invus Global Management, LLC3.50%4,964,650
Siren, L.L.C.3.50%4,964,650
Avicenna Life Sci Master Fund LP0.50%692,455
Avicenna Life Sci Master GP LLC0.50%692,455
Ulys, L.L.C.0.50%692,455
Raymond Debbane4.00%5,657,105

Source

View original at SEC

Related